Concepedia

James L. Speyer

JL

Statistics

Publications

62

Citations

5.3K

H-Index

37

Active since

1979

Affiliations

New York University(Current)

Columbia University Irving Medical Center

NYU Langone Health

Stanley Foundation

Kaplan (United States)

James L. Speyer is an author at New York University specializing in medicine, oncology, and chemotherapy.

Publications per year

1979–2017

62

Publications

62

Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Sandra M. Swain, Fredrick S. Whaley, Mirjam C. Gerber et al. · Journal of Clinical Oncology · 1997 · 652 citations

, , +16

Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast Cancer

James L. Speyer, Michael D. Green, E Douglas Kramer et al. · New England Journal of Medicine · 1988 · 355 citations

, , +17

ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.

James L. Speyer, M D Green, Anne Zeleniuch‐Jacquotte et al. · Journal of Clinical Oncology · 1992 · 323 citations

, , +17

Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols.

Raymond F. Greene, Jerry M. Collins, Jean Jenkins et al. · PubMed · 1983 · 294 citations

, , +17

Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally.

James L. Speyer, Jerry M. Collins, Robert L. Dedrick et al. · PubMed · 1980 · 252 citations

, , +14

1–5 of 62